RxElite, Inc.
RXEI
$0.00
$0.000.00%
OTC PK
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Revenue | 3.26M | 3.01M | 3.00M | 1.18M | 754.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.26M | 3.01M | 3.00M | 1.18M | 754.00K |
| Cost of Revenue | 2.95M | 2.50M | 2.64M | 1.34M | 623.40K |
| Gross Profit | 306.50K | 502.70K | 357.30K | -169.50K | 130.50K |
| SG&A Expenses | 3.15M | 3.34M | 2.37M | 3.90M | 2.18M |
| Depreciation & Amortization | 328.60K | 292.30K | 310.20K | 56.60K | 61.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.41M | 6.08M | 5.47M | 6.00M | 3.76M |
| Operating Income | -3.16M | -3.07M | -2.47M | -4.82M | -3.01M |
| Income Before Tax | -10.97M | -6.39M | -7.04M | -4.84M | -3.16M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.97M | -6.39M | -7.04M | -4.84M | -3.16M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.97M | -6.39M | -7.04M | -4.84M | -3.16M |
| EBIT | -3.16M | -3.07M | -2.47M | -4.82M | -3.01M |
| EBITDA | -2.45M | -2.51M | -2.00M | -4.59M | -2.89M |
| EPS Basic | -0.09 | -0.05 | -0.06 | -0.05 | -0.04 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.04 | -0.03 | -0.02 |
| EPS Diluted | -0.09 | -0.05 | -0.06 | -0.05 | -0.04 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.04 | -0.03 | -0.02 |
| Average Basic Shares Outstanding | 116.54M | 116.32M | 115.08M | 88.55M | 78.80M |
| Average Diluted Shares Outstanding | 116.54M | 116.32M | 115.08M | 88.55M | 78.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |